Media Center

 

Third Rock News & Events

January 26, 2017 - Third Rock Ventures Names Sarah Larson as Partner
» Read More

October 31, 2016 - Third Rock Ventures Raises $616 Million Fund IV
» Read More

September 24, 2016 - Third Rock Ventures’ Venture Partner Phil Reilly to receive the Henri Termeer Lifetime Achievement Award at the 5th Annual Tribute to Champions of Hope
» Read More

May 23, 2016 - Third Rock Ventures’ Venture Partner Phil Reilly to Speak at MassBio Event to Discuss his New Book “Orphan: The Quest to Save Children with Rare Disease”
» Read More

April 25, 2016 - Third Rock Ventures' Partner, Robert Tepper, to Moderate Panel at the World Medical Innovation Forum
» Read More

April 6, 2016 - Third Rock Ventures' Partner, Cary Pfeffer, to Present at Xconomy's EXOME: What's Hot in Boston Biotech
» Read More

Portfolio News

Myokardia
January 19, 2018 - MyoKardia Announces Appointment of Cynthia Ladd as General Counsel
» Press Release | Company News

Agios Pharmaceuticals
January 18, 2018 - Agios Announces Pricing of $475 Million Public Offering of Common Stock
» Press Release | Company News

Agios Pharmaceuticals
January 17, 2018 - Agios Announces Proposed Offering of Common Stock
» Press Release | Company News

Constellation Pharmaceuticals
January 16, 2018 - Constellation Pharmaceuticals Announces Initiation of Phase 1b/2 Study of CPI-1205
» Press Release | Company News

Foundation Medicine
January 16, 2018 - Foundation Medicine and Pfizer Announce Broad Partnership to Develop Companion Diagnostics for Pfizer's Oncology Portfolio
» Press Release | Company News

Global Blood Therapeutics
January 9, 2018 - GBT Receives FDA Breakthrough Therapy Designation for Voxelotor for Treatment of Sickle Cell Disease (SCD)
» Press Release | Company News

Editas Medicine
January 8, 2018 - Editas Medicine Reports on Recent Progress and Announces “EM22” Five-year Goals at J.P. Morgan Healthcare Conference
» Press Release | Company News

Foundation Medicine
January 8, 2018 - Foundation Medicine Reports Preliminary 2017 Results
» Press Release | Company News

SAGE Therapeutics
January 8, 2018 - Sage Therapeutics to Provide Pipeline Update at J.P. Morgan Healthcare Conference and Outline Key 2018 Initiatives to Support Planned Evolution to a Fully-Integrated Commercial Biopharmaceutical Company
» Press Release | Company News

Kala Pharmaceuticals
January 5, 2018 - Kala Pharmaceuticals Announces Topline Results for Two Phase 3 Trials (STRIDE 1 and STRIDE 2) of KPI-121 0.25% in Dry Eye Disease
» Press Release | Company News

News Archives